Deubiquitinase inhibition as a cancer therapeutic strategy (Q38274749)

1 September 2017

1 reference

title

Deubiquitinase inhibition as a cancer therapeutic strategy (English)

1 reference

1 September 2017

3

Stig Linder

1 reference

1 September 2017

Padraig D'Arcy

1

1 reference

1 September 2017

Xin Wang

series ordinal

2

1 reference

1 September 2017

publication date

6 November 2014

1 reference

Pharmacology & Therapeutics

1 September 2017

published in

1 reference

1 September 2017

volume

147

1 reference

1 September 2017

page(s)

32-54

1 reference

The nuclear deubiquitinase BAP1 is commonly inactivated by somatic mutations and 3p21.1 losses in malignant pleural mesothelioma

1 September 2017

cites work

1 reference

31 March 2022

https://opencitations.net/index/coci/api/v1/citations/10.1038/NG.855

RETRACTED: Selective killing of cancer cells by a small molecule targeting the stress response to ROS

1 reference

30 December 2023

https://opencitations.net/index/api/v1/citations/10.1038/NATURE10167

Quantitative reactivity profiling predicts functional cysteines in proteomes

1 reference

9 October 2024

https://opencitations.net/index/api/v1/citations/10.1038/NATURE09472

Identifiers

DOI

10.1016/J.PHARMTHERA.2014.11.002

1 reference

release_kdpike2wwbgjdgomxnvce5yara

1 September 2017

Fatcat ID

1 reference

https://api.fatcat.wiki/v0/release/kdpike2wwbgjdgomxnvce5yara

Fatcat

reference URL

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference